PB2452 | Friends of Cancer Research

You are here

PB2452

Sponsor: 
PhaseBio Pharmaceuticals
Indication: 
Reversal agent for the antiplatelet drug ticagrelor
Category: 
Year: 
2019
Date: 
Apr 8th
FDA Status: 
Designation Granted